Enhancement of immunity and resistance in mice by pig IL-6 gene and CpG motifs encapsulated in chitosan nanoparticle

Biotechnology Journal

Volumn 3, Issue 2, 2008, Pages 264-273

  Chen, Qian ^a   Zhao, Zhong Zhong ^a   Peng, Rong ^a   Wang, Ying Yu ^a   Xie, Zhao ^a   Wang, Ze Zhou ^a   Li, Jiang Lin ^a   Lv, Xue Bing ^a   Wu, Kai Yuan ^a   Fu, Man Liang ^a   Wang, Hong Ning ^a   Gao, Rong ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Chitosan nanoparticle; CpG motif; Immunity; Mice; Porcine IL 6 gene

Indexed keywords

CHITOSAN NANOPARTICLE; IMMUNITY;

ENCAPSULATION; GENETIC ENGINEERING; IMMUNOLOGY; NANOPARTICLES; NUCLEOTIDES;

CHITOSAN;

CHITOSAN; CPG OLIGODEOXYNUCLEOTIDE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; NANOPARTICLE; IMMUNOLOGICAL ADJUVANT; OLIGODEOXYRIBONUCLEOTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL IMMUNITY; BACTERIAL INFECTION; BACTERIAL VIRULENCE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CROSS LINKING; DISEASE SEVERITY; DRUG EFFICACY; DRUG POTENTIATION; DRUG RESPONSE; ENCAPSULATION; FEMALE; HEMOLYTIC STREPTOCOCCUS; IMMUNOGLOBULIN BLOOD LEVEL; INFECTION RESISTANCE; INOCULATION; LYMPHOCYTE COUNT; MONOCYTE; MONOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECOMBINANT PLASMID; SEROTYPE; SYMPTOM; ANIMAL; BLOOD; CHEMISTRY; CPG ISLAND; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; PATHOGENICITY; PLASMID; STREPTOCOCCUS INFECTION; STREPTOCOCCUS SUIS; SWINE; TIME; VIRULENCE;

ANIMALIA; MUS; STREPTOCOCCUS; SUIDAE; SUS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CHITOSAN; CPG ISLANDS; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNITY, NATURAL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-6; MICE; NANOPARTICLES; OLIGODEOXYRIBONUCLEOTIDES; PLASMIDS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS SUIS; SWINE; TIME FACTORS; VIRULENCE;

EID: 41049117583     PISSN: 18606768     EISSN: None     Source Type: Journal    
DOI: 10.1002/biot.200700050     Document Type: Article

References (29)

1. Leclerc, C., Ronco, J., New approaches in vaccine development. Immunol. Today, 1998, 19, 300-302.
2. Doing, P. Brunn, C., Ho, R. J., Cytokines as vaccine adjuvants: Current status and potential applications, in: Powell, M. F., Newman, M. J. (Eds.), Vaccine design: The subunit and adjuvant approach, Plenum Press, New York 1995. pp. 625-643.
3. Dobryszycka, W., Relevance of haptoglobin in clinical medicine. Folia Histochem. Cytobiol. 1992, 30, 197-200.
4. Scott, P. R., Murray L. D., Penny C. D., A preliminary study of as a prognostic indicator of ovine dystocia cases. Br. Vet. J. 1992, 148, 351-355.
5. Emery, P., Luqmani, R., The validity of surrogate markers in rheumatic disease. Br. J. Rheumatol. 1993, 32, 3-8.
6. Kishimoto, T., Interleukin-6: From basic science to medicine - 40 years in immunology. Annu. Rev. Immunol. 2005, 23, 1-21.
7. Murtaugh, M. P., Porcine cytokines. Vet. Immunol. Immunopathol. 1994, 43, 37-44.
8. Kim, J. J., Yang, J. S., VanCott, T. C., Lee, D. J. et al., Modulation of antigen-specific humoral responses in Rhesus Macaques by using cytokine cDNA as DNA vaccine adjuvants. J. Virol. 2000, 74, 3427-3429.
9. Anders, H. J., Banas, B., Linde, Y., Grone, H. J. et al., Bacterial CpG-DNA aggravates immune complex glomerulonephritis: Role of TLR9-mediated expression of chemokines and chemokine receptors. J. Am. Soc. Nephrol. 2003, 14, 317-326.
10. Ashkar, A. A., Rosenthal, K. L., Toll-like receptor 9, CpG DNA and innate immunity. Curr. Mol. Med. 2002, 2, 545-556.
11. Zhou, X., Zheng, L., Liu, L., Xiang, L. et al., T helper 2 immunity to hepatitis B surface antigen primed by gene-gun-mediated DNA vaccination can be shifted towards T helper 1 immunity by codelivery of CpG motif-containing oligodeoxynucleotides. Scand. J. Immunol. 2003, 58, 350-357.
12. Kojima, Y., Xin, K. Q., Ooki, T., Hamajima, K. et al., Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine. Vaccine 2002, 20, 2857-2865.
13. Weeratna, R. D., Mccluskie, M. J., Xu, Y., Davis, H. L., CpG DNA induces stronger immune responses with less toxicity than other adjuvants. Vaccine 2000, 18, 1755-1762.
14. Bauer, S., Kirschning, C. J., Hacker, H., Redecke, V. et al., Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition.Proc. Natl. Acad. Sci. USA 2001, 98, 9237-9242.
15. Hartmann, G., Weiner, G. J., Krieg, A. M., CpG DNA: A potent signal for growth, activation, and maturation of human dendritic cells. Proc. Natl. Acad. Sci. USA 1999, 96, 9305-9310.
16. Klinman, D. M., Kamstrup, S., Verthelyi, D., Gursel, I. et al., Activation of the innate immune system by CpG oligodeoxynucleotides: Immunoprotective activity and safety. Springer Semin. Immunopathol. 2000, 22, 173-183.
17. Rankin, R., Pontarollo, R., Gomis, S., Karvonen, B. et al., CpG-containing oligodeoxynucleotides augment and switch the immune responses of cattle to bovine herpesvirus-1 glycoprotein D. Vaccine 2000, 20, 3014-3022.
18. Krieg, A.M., Yi, A.K., Matson, S., Waldschmidt, T. J. et al., CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995, 374, 546-549.
19. Wu, K. Y., Wu, M., Fu, M. L., Gao R. et al., A novel chitosan CpG nanoparticle regulates cellular and humoral immunity of mice. Biomed. Environ. Sci. 2006, 19, 87-95.
20. Murphy, J. C., Wibbenmeyer, J. A., Fox, G. E., Willson, R. C., Purification of plasmid DNA using selective precipitation by compaction agents. Nat. Biotechnol. 1999, 17, 822-823.
21. Ogikubo Y., Norimatsu M., Noda K., Takahashi J. et al. Evaluation of the bacterial endotoxin test for quantification of endotoxin contamination of porcine vaccines. Biologicals 2004, 32, 88-93.
22. Yang, Y., Chen, J. L., Li. H., Gao R. et al., Porcine interleukin-2 gene encapsulated in chitosan nanoparticles enhances immune response of mice to piglet paratyphoid vaccine. Comp. Immunol. Microbiol. Infect. Dis. 2007, 30, 19-32.
23. Krieg, A. M., Antitumor applications of stimulating toll-like receptor 9 with CpG oligodeoxynucleotides. Curr. Oncol. Rep. 2004, 6, 88-95.
24. Wu, M., Gao, R., Meng, M. J., Li, J. L. et al., Regulating effects of porcine interleukin-6 gene and CpG motifs on immune responses to porcine trivalent vaccines in mice. Res. Vet. Sci. 2004, 77, 49-57.
25. Li, J. L, Gao, R., Wu, M., Meng, M. J. et al., The effect of transgenic expression of porcine interleukin-6 gene and CpG sequences on immune responses of mice inoculated with the gene vaccine of Taenia solium of pig. High Technol. Lett. 2002, 6, 26-30.
26. Felt, O., Buri, P., Gurny, R., Chitosan: A unique polysaccharide for drug delivery. Drug Dev. Ind. Pharm. 1998, 24, 979-993.
27. Mao, H. Q., Roy, K., Troung-Le, V. L., Janes, K. A. et al., Chitsan-DNA nanoparticles as gene carriers: Synthesis, characterization and transfection efficiency. J. Control Release 2001, 70, 399-421.
28. Corsi, K., Chellat, F., Yahia, L., Fernandes, J. C., Mesenchymal stem cells. MG63 and HEK293 transfection using chitosan-DNA nanoparticles. Biomaterials 2003, 24, 1255-1264.
29. Calvo, P., Remunan-Lopez, C., Vila-Jato, J. L., Alonson, M. J., Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines. Pharm. Res. 1997, 14, 1431-1436.